000 01601 a2200433 4500
005 20250516002615.0
264 0 _c20110118
008 201101s 0 0 eng d
022 _a1460-2091
024 7 _a10.1093/jac/dkq335
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPfaller, Michael A
245 0 0 _aTelavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cNov 2010
300 _a2396-404 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAminoglycosides
_xpharmacology
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aAsia
650 0 4 _aCross Infection
_xmicrobiology
650 0 4 _aCulture Media
_xchemistry
650 0 4 _aEurope
650 0 4 _aGram-Positive Bacteria
_xdrug effects
650 0 4 _aGram-Positive Bacterial Infections
_xmicrobiology
650 0 4 _aHumans
650 0 4 _aLatin America
650 0 4 _aLipoglycopeptides
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aNorth America
650 0 4 _aPacific Islands
650 0 4 _aPneumonia, Bacterial
_xmicrobiology
650 0 4 _aRespiratory System
_xmicrobiology
650 0 4 _aUnited States
700 1 _aMendes, Rodrigo E
700 1 _aSader, Helio S
700 1 _aJones, Ronald N
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 65
_gno. 11
_gp. 2396-404
856 4 0 _uhttps://doi.org/10.1093/jac/dkq335
_zAvailable from publisher's website
999 _c20177447
_d20177447